Navigation Links
Global Pharmaceutical Outsourcing Market Report 2015 - New Trends on the Horizon

DUBLIN, Apr. 10, 2015 /PRNewswire/ --Research and Markets

( has announced the addition of the "The New Trends of Global Pharmaceutical Outsourcing - Second Edition" report to their offering.

The escalating operation cost for every drug company and the vigorous control of the healthcare cost by the government in almost all countries, coupled with the low efficiency in their operation for a number of years, have forced all drug companies to seriously address these issues. Streamlining their internal operation and more diligently seeking external resources have become their core strategies.

Besides the operational factors, the fast emerging of new technologies in drug R&D has also forced drug companies to rapidly adapt to the new R&D environment. Today, drug companies are in a desperate need to develop better drugs with high success rates and low cost. To achieve these goals, they increasingly resort to the combination of internal effort and external resources.

The report, The New Trends of Global Pharmaceutical Outsourcing - Second Edition, provides unique insights into the new outsourcing demands and strategies of global drug companies large and small in both R&D and manufacturing and in both small molecules and biologics. The report helps professionals in the life science-related industries gain a better view about what is really going on currently in the global pharmaceutical outsourcing industry. It also includes the in-depth analyses on the new outsourcing models currently practiced by drug companies.

The report provides the unique insights into the latest trends of the global pharmaceutical outsourcing in both R&D and manufacturing, in both small molecules and biologics, and in both major pharma companies and R&D-focused biotech companies. It is a must-read book to all pharmaceutical and biotechnology companies that seek outsourcing opportunities in both R&D and manufacturing, professional outsourcing service providers that need to conceive their future business development directions, and venture capital investors that are looking for investment opportunities in the global pharmaceutical industry.

Key Topics Covered:

Executive Summary
Global drug companies' new outsourcing demands
New trends in drug discovery outsourcing
New trends in drug development outsourcing
New trends in pharmaceutical manufacturing outsourcing

Chapter One - Global Drug Companies' New Outsourcing Demands
1.1 Introduction
1.2 Major pharma companies forced to increase outsourcing
1.3 Disease biology-focused drug discovery approaches forcing drug companies to seek external partners
1.4 Strong outsourcing demands from global drug R&D-focused small biotech companies

Chapter Two - New Trends in Drug Discovery Outsourcing

2.1 Introduction
2.2 New trends in compound library development
2.3 New trends in target discovery outsourcing
2.4 New drug discovery partnership models with academics
2.5 Drug companies' new outsourcing strategies and models on small molecule drug discovery
2.6 Major pharma companies' new strategies on biologic drug discovery outsourcing
2.7 New trends in IND-enabling drug discovery outsourcing

Chapter Three - New Trends in Drug Development Outsourcing

3.1 Introduction
3.2 New developments in clinical trials
3.3 New technologies incorporated into clinical trials and drug companies' new outsourcing strategies in these areas
3.4 Drug companies' new clinical trial outsourcing strategies
3.5 Clinical trial CRO consolidation becoming a trend

Chapter Four - New Trends in Pharmaceutical Manufacturing Outsourcing

4.1 Introduction
4.2 Major pharma companies' new outsourcing strategies on small molecule drug manufacturing
4.3 R&D-focused small biotech companies' current outsourcing demands and strategies for small molecule manufacturing services
4.4 Small molecule manufacturing service-focused CMOs experiencing significant consolidations
4.5 Latest trends of small molecule manufacturing outsourcing in emerging countries
4.6 New trends in biomanufacturing outsourcing
4.7 Major pharma companies' new outsourcing demands and strategies on biologic product manufacturing
4.8 New biomanufacturing outsourcing demands and strategies of R&D-focused small biotech companies

For more information visit

Media Contact: Laura Wood , +353-1-481-1716,

SOURCE Research and Markets
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Orally Inhaled Bronchodilators Market to 2022
2. Porzio Life Sciences bietet mit Gründung von Porzio GST und Standort in den Niederlanden globale Compliance- und Kommerzialisierungsdienste an
3. Porzio Life Sciences Offers Global Compliance and Commercialization Services with Launch of Porzio GST and Netherlands Office
4. Global Laboratory Information Management System (LIMS) Market 2015-2019 - Increasing Popularity of Cloud LIMS
5. Global In-vitro Fertilization (IVF) Devices Market 2015-2019 with Cook Medical, Cooper Surgical, Irvine Scientific Sales & Vitrolife Dominating
6. Endoscopy Systems - Global Strategic Business Report 2015-2020: New Applications Drive Rigid Endoscopy Market
7. PointNurse Partners with Swarm to Create first Global Distributed Telemedicine and Telehealth Collaborative Organization
8. Magnetic Resonance Imaging (MRI) Equipment - Global Strategic Business Report 2015-2020: GE Healthcares Silent Scan Technology: A Major Technological Breakthrough
9. Diagnostic Imaging Technologies Global Market - Forecast to 2020: Market is expected to reach approximately $27.1 billion
10. Global Hyperspectral Imaging Market is Expected to Reach $74.29 Million by 2019, at a CAGR of 12.0% From 2014 to 2019
11. Delcath Adds New U.S. Center To Global Phase 2 Hepatocellular Carcinoma Program
Post Your Comments:
(Date:10/11/2017)... Calif. , Oct. 11, 2017  BioPharmX Corporation ... scientific team that developed an innovative way to use ... of the delivery of new drugs. ... Fall Clinical Dermatology Conference will show how researchers from ... Hospital, Harvard Medical School used a suite of imaging ...
(Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017  NDS received FDA 510(k) ... — a medical-grade battery-powered display stand specifically designed for endoscopy environments. ... transform technology into a clinical solution to support the improvement of ... Innovative Design ... Mobile Wireless Solution ...
Breaking Medicine Technology:
(Date:10/13/2017)... Worth, TX (PRWEB) , ... October 13, 2017 ... ... financial planning agency serving communities in the greater Dallas, Miami, and Raleigh regions, ... young boy fighting to overcome a rare and deadly chromosome abnormality. , After ...
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important ... problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , She developed ... darkness or restricted lighting. As such, it eliminates the need to turn on a ...
(Date:10/13/2017)... ... 13, 2017 , ... PurhealthRX , a leading Health and Nutrition Company, ... Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market by ... be easily incorporated into liquid products, while reducing costs to end users. , The ...
(Date:10/13/2017)... ... ... Apple Rehab Shelton Lakes , which specializes in the delivery of ... part of a disaster drill on October 3rd. , Apple Rehab participated with the ... as well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). The ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for ... for action towards gender equality at their inaugural Summit in New York City in ... reached a social audience of over 3 million. To watch the Mobilize Women video, ...
Breaking Medicine News(10 mins):